[Structure and mode of injection of the oncoprotein CagA of Helicobacter pylori].
Burcu
B
Kaplan-Türköz
Laurent
L
Terradot
D000818:Animals; D000942:Antigens, Bacterial / Q000737:chemistry* / Q000378:metabolism*; D001426:Bacterial Proteins / Q000737:chemistry* / Q000378:metabolism*; D016481:Helicobacter Infections / Q000150:complications; D016480:Helicobacter pylori; D006801:Humans; D039081:Integrin alpha5beta1 / Q000378:metabolism; D018442:Lymphoma, B-Cell, Marginal Zone / Q000209:etiology; D051379:Mice; D008822:Mice, Transgenic; D015394:Molecular Structure; D015513:Oncogene Proteins; D013274:Stomach Neoplasms / Q000209:etiology
D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D039081:Integrin alpha5beta1; D015513:Oncogene Proteins; C080866:cagA protein, Helicobacter pylori